Article Details

Temasek-backed Pavilion Capital backs funding in AI biopharma firm Insilico

Retrieved on: 2018-06-11 08:56:15

Tags for this article:

Click the tags to see associated articles and topics

Temasek-backed Pavilion Capital backs funding in AI biopharma firm Insilico. View article details on hiswai:

Excerpt

<div>“The funding is intended to enhance <b>Insilico Medicine's</b> work in the innovative approaches to the generation of novel molecules using a variety of ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up